NewLink enters $150M deal to fund cancer therapy work

October 20, 2014 1:09 PM

4 0

An Ames-based pharmaceutical company has entered into a $150 million deal to further develop its cancer therapies.

NewLink Genetics said today that it has entered into an exclusive license agreement with Genentech, a San Francisco-based biotechnology firm.

Also read: Southeast Asian Nations Assess Options Amid Likely Demise of Trade Deal

Read more

To category page

Loading...